# Effect of Anatabine on Elevated Blood Levels of C-reactive Protein

> **NCT01607619** · NA · COMPLETED · sponsor: **Roskamp Institute Inc.** · enrollment: 117 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DIETARY_SUPPLEMENT:** Anatabine

## Key facts

- **NCT ID:** NCT01607619
- **Lead sponsor:** Roskamp Institute Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01607619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01607619, "Effect of Anatabine on Elevated Blood Levels of C-reactive Protein". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01607619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*